Opioid Dispensing Device for Post-Operative Pain in Cancer Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorColumbia University

About this trial

This research study will evaluate the use of, and participants experience with, a new device called Addinex that safely stores and dispenses opioid medication. The purpose of this study is to evaluate the use of the Addinex device in cancer patients undergoing cancer-related surgery that require pain control with opioids after the surgery. Participants will be asked to answer questions about their medical history and background, fill out questionnaires, use a mobile application associated with the device, and undergo a phone interview one month after stopping use of the device. This study aims to find out how participants like using the Addinex device as opposed to a traditional pill bottle. Results of this study will help determine if the Addinex device could be useful to patients in the future after surgeries, as opposed to typical pill bottles.

Eligibility criteria

Qualifiers

Adult patients (age greater than or equal to 18 years)

Planned for major cancer-related surgery and expected to receive a postoperative opioid prescription

Must speak English or Spanish

Must have access to a smartphone or an alternative smart device (e.g., iPhone, Android phone, iPad, Surface, etc.).

Disqualifiers

Patients who are taking opioids daily prior to the surgical procedure

Patients unable to physically utilize the device

Patients unable to self-administer medications

Patients uncomfortable with using iPhone or iPad-based technology

Trial design

Treatments tested in this trial

  • Addinex Device (ADX-27)

Treatment groups

140 Participants
are divided into 1 treatment group

Sponsors and collaborators

Columbia University

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator